Breaking Woman Recants Sexual Assault Allegations Against Jay-Z in Court Filing Therapist Shares Calming Techniques for Parents Amidst Stress Mahershala Ali Stars as Devout Muslim Hitman in New Film “Your Mother Your Mother Your Mother” President Trump and President Xi Convene Amidst Global Diplomatic Engagements Specific Pokémon Set Value Declines, Mew ex Card from 30th Celebration Cited

Friday September 25, 2026

Section

Business

Press Release

Top 10 Reputable Pet Bathtub Manufacturers in China 2026: Advancing Hygienic Grooming Solutions

Written By: EIN Presswire · Sep 14

Press Release

Open Secure AI Alliance Joins the Linux Foundation to Build a Shared, Open Defense Stack for the AI Era

The Linux Foundation · Sep 14

Press Release

Stäubli Expands BosCon Portfolio with Permanent Protective Caps and Panel Receptacles for Enhanced Protection and Performance

Stäubli Electrical Connectors · Sep 14

Press Release

Cohen & Co Welcomes Partner Rory Wilson to Lead Forensic Services Group

Cohen & Co · Sep 14

Press Release

Matthew McConaughey to Keynote Filevine’s LEX Summit 2026

Filevine · Sep 14

Press Release

The Land Of Balance Turns Young Love Into An Adventure Between Darkness And Light

Written By: EIN Presswire · Sep 14

Press Release

GENFIT Advances Nangibotide in Phase 2 Clinical Investigation in ACLF

GENFIT S.A. · Sep 14

Press Release

KFSH Riyadh Records Zero High-Risk Findings Across Nearly 1,800 Measures in JCI Reaccreditation

King Faisal Specialist Hospital & Research Centre · Sep 14

Press Release

DeepSafe Publishes Three-Stage Verification Pipeline Behind Its Cross-Chain Signatures

DeepSafe · Sep 14

Press Release

Smile Makeover Market Growth Rate Expected To Reach 8.4% CAGR By 2030

Written By: EIN Presswire · Sep 14

Press Release

Enhertu® Demonstrated a Median Progression-Free Survival of 14.3 Months as First-Line Therapy in Patients with HER2 Mutant Advanced Non-Small Cell Lung Cancer in DESTINY-Lung04 Phase 3 Trial

Business Wire · Sep 14

Press Release

ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 14.3 months as 1st-line therapy in patients with HER2-mutant advanced non-small cell lung cancer in DESTINY-Lung04 Phase III trial

Business Wire · Sep 14

Press Release

Mitsubishi Electric’s New Plate Heat Exchanger Delivers 3x Conventional Heat Transfer Performance

Business Wire · Sep 14

← Previous 1 … 1,502 1,503 1,504 … 1,567 Next →